Biotechnology and its Applications — GM Crops, Gene Therapy and Biosafety

This chapter turns the tools of the last one into real products, and it is mostly a set of flagship examples you should be able to name and explain in one line each: Bt cotton, RNAi against nematodes, golden rice, human insulin from bacteria, gene therapy, and molecular diagnostics. The examiner's favourite is how genetically engineered human insulin is made — the trick of producing the two chains separately and joining them — so understand that one properly. The chapter closes with biosafety and ethics (biopiracy, the GEAC, patents), which are direct recall. Learn each application as a short story — the problem, the genetic fix, the benefit — and the answers write themselves.

Biotechnology in Agriculture

  • Bt cotton carries a gene (cry) from Bacillus thuringiensis that makes a protein toxic to bollworms. The toxin is made as an inactive protoxin, harmless until the alkaline gut of the insect activates it — which is why it kills the pest but not the plant or us.
  • RNA interference (RNAi) protects plants against nematodes: introducing a gene that makes double-stranded RNA silences a vital nematode gene, so the parasite cannot survive in the plant. It is a defence based on gene silencing.
  • Golden rice is engineered to make beta-carotene (pro-vitamin A) in the grain, to combat vitamin-A deficiency. GM crops in general aim at pest resistance, better nutrition, and reduced post-harvest loss.
🎯 Why the Bt toxin kills the pest but is safe for the plant and for us
It sounds alarming that a plant is made to produce an insect toxin in its own tissue — surely that would harm the plant, or us when we eat it? The elegant safety trick is that the toxin is not made in its active form. The cry gene produces the toxin as an inactive protoxin, a crystal protein that does nothing on its own. It is activated only under two specific conditions found together in the target insect's gut: a high (alkaline) pH and specific gut enzymes. When a bollworm eats the plant, its alkaline midgut converts the protoxin into the active toxin, which then binds the insect's gut lining and kills it. The plant's own cells are not alkaline in this way, so the protoxin sits harmlessly; and the human stomach is strongly acidic, not alkaline, so we digest the protein as ordinary food without ever activating it. This conditional activation is the whole reason Bt crops are considered selective and safe: the poison only becomes a poison inside the specific pest. When a question asks why the Bt protein does not harm the plant, the answer is that it remains an inactive protoxin until the insect's alkaline gut switches it on.

Biotechnology in Medicine

  • Genetically engineered insulin (Humulin): human insulin has two chains, A and B, joined by disulphide bridges. The engineered version is made by producing the two chains separately in E. coli, then joining them chemically — avoiding the extra C-peptide that natural pro-insulin has.
  • Gene therapy treats a genetic disorder by delivering a correct gene into the patient's cells. The first case treated ADA deficiency (adenosine deaminase, a severe immune disorder) — but since the corrected cells were not permanent, the treatment had to be repeated.
  • Molecular diagnostics detect disease early, before symptoms: PCR amplifies a pathogen's tiny amount of nucleic acid; ELISA detects antigens or antibodies. Both find infection at levels too low for older methods.
⚠️ Engineered insulin: the whole trick is making the two chains separately
This is one of the most reliably examined details in the whole biotech unit, and it rewards knowing exactly what the difficulty was and how it was solved. Human insulin is a small protein of two chains, A and B, held together by disulphide bonds. In the body it is first made as a single longer chain, pro-insulin, which includes an extra stretch called the C-peptide; this C-peptide is later removed to give the mature, active insulin. The problem for biotechnologists was that simply making pro-insulin in bacteria would leave the C-peptide in place, giving an inactive form. The solution used by the company Eli Lilly in 1983 was neat: they prepared the two chains (A and B) separately, each from its own DNA sequence in E. coli, and then joined them together chemically by their disulphide bonds to make the finished insulin — sidestepping the C-peptide problem entirely. So the examinable point is the separate-chains-then-join strategy, and the trap answer is that engineered insulin is made as a single pro-insulin chain like the natural one. It is not; the whole innovation was to build the two mature chains apart and stitch them together.

Biosafety and Ethics

  • Biopiracy is the use of a country's bio-resources and traditional knowledge by others (often companies) without authorisation or fair payment. India's challenges to patents on turmeric, neem and basmati are the standard examples.
  • In India the GEAC (Genetic Engineering Appraisal Committee) approves GM research and the safety of releasing GM organisms for public use. Ethical concerns include patenting life forms, and the safety and labelling of GM foods.
ℹ️ Why biopiracy is a real problem and not just paperwork
Biopiracy can feel like a dry legal topic, but the underlying issue is a genuine injustice the exam wants you to grasp. For centuries, communities — especially in biodiversity-rich countries like India — have developed knowledge about which plants heal, nourish or protect crops. This knowledge, and the organisms it concerns, are a shared inheritance. Biopiracy is when a company from elsewhere takes that resource or that knowledge, patents it, and then claims the exclusive right to profit from it — sometimes even charging the original community to use what they discovered. The classic Indian cases show the pattern: patents were granted abroad on the wound-healing use of turmeric, on neem's pesticidal properties, and on basmati rice, all long known in India, and India had to fight to have them overturned. The wider point the chapter makes is that biotechnology is powerful enough to convert shared biological heritage into private property, so laws and bodies exist to prevent unfair exploitation and to ensure that the countries and communities providing the resources share in the benefits. In an exam, "biopiracy" should trigger the idea of unauthorised use of bio-resources or traditional knowledge without fair benefit-sharing, illustrated by turmeric, neem and basmati.

Key takeaways

  • Bt cotton makes an inactive protoxin from a cry gene; the insect's alkaline gut activates it, so it kills the pest but not the plant/us.
  • RNAi silences a vital gene of the nematode via double-stranded RNA — a gene-silencing defence.
  • Golden rice makes beta-carotene (pro-vitamin A) in the grain to fight vitamin-A deficiency.
  • Engineered insulin: the A and B chains are made SEPARATELY in E. coli, then joined chemically (no C-peptide issue).
  • Gene therapy delivers a correct gene into the patient's cells; the first case treated ADA deficiency.
  • Molecular diagnostics: PCR amplifies pathogen nucleic acid, ELISA detects antigen/antibody — both find disease early.
  • Biopiracy = unauthorised use of bio-resources / traditional knowledge (turmeric, neem, basmati are the Indian examples).
  • In India the GEAC approves GM research and the safe release of GM organisms.

Practice questions (8)

Attempt each one before opening the answer. Every explanation names the tempting wrong option as well as the right one, because that is where marks are lost.

  1. The Bt toxin produced in Bt cotton does not harm the plant itself because it is:

    1. An inactive protoxin, activated only in the alkaline gut of the insect
    2. Made only at night
    3. Destroyed by sunlight before it acts
    4. Confined to the roots
    Show answer

    Answer: A — An inactive protoxin, activated only in the alkaline gut of the insect

    The cry gene makes an inactive protoxin that only becomes toxic in the alkaline midgut of the feeding insect, so it spares the plant and, given our acidic stomach, spares us too. The other options invent mechanisms that are not how Bt selectivity works.

  2. Genetically engineered human insulin (Humulin) is produced by:

    1. Making the A and B chains separately in E. coli and then joining them
    2. Extracting it directly from human blood
    3. Producing intact pro-insulin with its C-peptide in bacteria
    4. Chemically synthesising it without any cells
    Show answer

    Answer: A — Making the A and B chains separately in E. coli and then joining them

    The two chains are produced separately in E. coli and then linked by disulphide bonds, avoiding the C-peptide of natural pro-insulin. Producing intact pro-insulin would leave the C-peptide in place and give an inactive form, which is exactly the problem the separate-chain method solves.

  3. Golden rice has been genetically engineered to be rich in:

    1. Beta-carotene (pro-vitamin A)
    2. Vitamin C
    3. Iron only
    4. Protein only
    Show answer

    Answer: A — Beta-carotene (pro-vitamin A)

    Golden rice makes beta-carotene, a precursor of vitamin A, to address vitamin-A deficiency in populations dependent on rice. It is not engineered for vitamin C or protein, so those options name the wrong target nutrient.

  4. The first clinical use of gene therapy was for a patient with a deficiency of:

    1. Adenosine deaminase (ADA)
    2. Insulin
    3. Haemoglobin
    4. Thyroxine
    Show answer

    Answer: A — Adenosine deaminase (ADA)

    The first gene therapy targeted ADA deficiency, a severe immune disorder, by introducing a functional ADA gene into the patient's cells. Insulin and thyroxine deficiencies are managed by supplying the hormone, not by this early gene-therapy case.

  5. RNA interference (RNAi) is used to protect tobacco plants from a nematode by:

    1. Silencing a vital gene of the nematode with double-stranded RNA
    2. Poisoning the soil around the roots
    3. Making the plant grow faster than the nematode
    4. Attracting predators of the nematode
    Show answer

    Answer: A — Silencing a vital gene of the nematode with double-stranded RNA

    The plant is engineered to produce double-stranded RNA that silences a gene essential to the nematode, so the parasite cannot survive in it — gene silencing, not poisoning or growth competition. The other options describe mechanisms RNAi does not use.

  6. India's challenges to foreign patents on turmeric, neem and basmati are classic examples of resisting:

    1. Biopiracy
    2. Gene therapy
    3. Insertional inactivation
    4. Fermentation
    Show answer

    Answer: A — Biopiracy

    Patenting long-known Indian bio-resources and traditional knowledge without authorisation or benefit-sharing is biopiracy, which these cases resisted. Gene therapy, insertional inactivation and fermentation are unrelated techniques, not the ethical issue at stake.

  7. In India, the body that approves genetically modified research and the release of GM organisms is the:

    1. GEAC (Genetic Engineering Appraisal Committee)
    2. ICMR
    3. ISRO
    4. RBI
    Show answer

    Answer: A — GEAC (Genetic Engineering Appraisal Committee)

    The GEAC evaluates GM research proposals and the safety of releasing GM organisms for public use. ICMR, ISRO and RBI govern medical research, space and banking respectively, so none of them oversees GM biosafety.

  8. Molecular diagnostic methods such as PCR are valuable because they can detect a pathogen:

    1. Very early, even when present in extremely low amounts
    2. Only after severe symptoms appear
    3. Only in dead tissue
    4. Without any nucleic acid present
    Show answer

    Answer: A — Very early, even when present in extremely low amounts

    PCR amplifies even tiny amounts of a pathogen's nucleic acid, so infection can be detected very early, before symptoms and long before older methods would notice it. It requires nucleic acid to amplify, so the "without any nucleic acid" option contradicts how PCR works.